Experts highlighted that India is only in the early stages of making progress, and so far, solutions have been found for just one type of disease, with many more still awaiting attention.

The use of paracetamol as a first line pain killer for long-term conditions such as osteoarthritis in older people needs to ...

A groundbreaking antipsychotic, a powerful new antibiotic, and a vaccine-like prophylactic for HIV are some of the most ...

High levels of harmful bacteria and medicines used to treat diabetes and seizures were discovered in samples collected from ...

A physician of endless curiosity and talents, Dr. O'Brien was “the most interesting person I’ve ever met,” said his son, TV ...

Insights into how diverse phage communities coexist within a single E. coli strain could lead to newer, more effective phage-based therapies.

Researchers say the findings raise concerns about antibiotic resistance from inappropriate use of broad-spectrum antibiotics.

The Chicago-based biopharma is growing its specialty portfolio through a licensing agreement for a novel antibiotic approved ...

Published online December 12 in the journal Science, a new study offers the first evidence that a single bacterial species—the host of the phage—can maintain a diverse community of competing phage ...

Africa saw a notable jump in mpox cases last week, with a continuing rise in novel clade 1b detections and shifts in ...

One of the most well-known real estate investors in Sacramento is facing allegations from two women of assault and sexual battery.

Meitheal Pharmaceuticals has gained exclusive US commercial rights for XENLETA for treating CABP in the adult population.